Targeting NXPH4/ALDH1L2 Signaling Suppresses Enzalutamide Resistance in Prostate Cancer

By
Emily Salmini
-
0
19
Investigators conducted gain- and loss-of-function studies in prostate cancer cell lines and mouse subcutaneous xenograft models to elucidate the role of Neurexophilin 4 (NXPH4) in CRPC.
[Cell Death Discovery]
Abstract